Background: The National Institute of Health Stroke Scale (NIHSS) results at baseline and after 1 year have never before been accounted for within an unselected population-based stroke sample. Neither has it been shown which individual items in the scale are the most important ones for the outcome in terms of death or dependency after 1 year. Methods: The subjects were all patients within a municipality who had their first-ever non-subarachnoidal stroke during 1 year (n = 377). Impairment was evaluated at baseline (within 24–48 h) and after 1 year with the 15-item version of the NIHSS. At the 1-year follow-up, the Modified Rankin Scale was used in order to determine which patients were dependent. Predictors of death and dependency were analysed in logistic regression models. The different NIHSS items, age and gender were used as independent variables. Results: The median NIHSS score was 6 (interquartile range 3–12) at baseline and 1 (interquartile range 0–3) at the 1-year follow-up, when 33% of the patients had died. Of patients scoring less than 4 on baseline NIHSS, 75% were functionally independent after 1 year. Seventeen per cent were functionally dependent and 8% were dead. Independent predictors of death were: age, questions, commands, gaze, alertness and sensation. Independent predictors of dependency were: age, commands, alertness and motor leg. Conclusions: Baseline NIHSS predicts the outcome after 1 year at the group level. Age and any reduction of the level of consciousness on arrival were associated with bad outcome after 1 year.

Kelly-Hayes M, Robertson JT, Broderick JP, Duncan PW, Hershey LA, Roth EJ, Thies WH, Trombly CA: The American Heart Association Stroke Outcome Classification. Stroke 1998;29:1274–1280.
Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M: Measurements of acute cerebral infarction: A clinical examination scale. Stroke 1989;20:864–870.
Goldstein LB, Bertels C, Davis JN: Interrater reliability of the NIH stroke scale. Arch Neurol 1989;46:660–662.
Lyden PD, Lu M, Levine SR, Brott TG, Broderick J: A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: Preliminary reliability and validity. Stroke 2001;32:1310–1317.
Meyer BC, Hemmen TM, Jackson CM, Lyden PD: Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: Prospective reliability and validity. Stroke 2002;33:1261–1266.
Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J: Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994;25:2220–2226.
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–1251.
Woo D, Broderick JP, Kothari RU, Lu M, Brott T, Lyden PD, Marler JR, Grotta JC: Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. Stroke 1999;30:2355–2359.
Goldstein LB, Samsa GP: Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997;28:307–310.
Dewey HM, Donnan GA, Freeman EJ, Sharples CM, Macdonell RA, McNeil JJ, Thrift AG: Interrater reliability of the National Institutes of Health Stroke Scale: Rating by neurologists and nurses in a community-based stroke incidence study. Cerebrovasc Dis 1999;9:323–327.
Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, Conroy MB, Localio AR: Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke 1999;30:1534–1537.
Williams LS, Yilmaz EY, Lopez-Yunez AM: Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke 2000;31:858–862.
Bushnell CD, Johnston DC, Goldstein LB: Retrospective assessment of initial stroke severity: Comparison of the NIH Stroke Scale and the Canadian Neurological Scale. Stroke 2001;32:656–660.
Muir KW, Weir CJ, Murray GD, Povey C, Lees KR: Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 1996;27:1817–1820.
Lai SM, Duncan PW, Keighley J: Prediction of functional outcome after stroke: Comparison of the Orpington Prognostic Scale and the NIH Stroke Scale. Stroke 1998;29:1838–1842.
Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD: Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126–131.
Frankel MR, Morgenstern LB, Kwiatkowski T, Lu M, Tilley BC, Broderick JP, Libman R, Levine SR, Brott T: Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology 2000;55:952–959.
Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T: Cerebrovascular disease in the community: Results of a WHO collaborative study. Bull World Health Organ 1980;58:113–130.
Sudlow CL, Warlow CP: Comparing stroke incidence worldwide: What makes studies comparable? Stroke 1996;27:550–558.
Appelros P, Nydevik I, Seiger Å, Terént A: High incidence rates of stroke in Örebro, Sweden: Further support for regional incidence differences within Scandinavia. Cerebrovasc Dis 2002;14:161–168.
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project–1981–86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990;53:16–22.
Rankin J: Cerebral vascular accidents in patients over the age of 60. Scott Med J 1957;2:200–215.
Bamford JM, Sandercock PA, Warlow CP, Slattery J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989;20:828.
Burn JP: Reliability of the modified Rankin Scale. Stroke 1992;23:438.
Duncan PW, Wallace D, Lai SM, Johnson D, Embretson S, Laster LJ: The Stroke Impact Scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke 1999;30:2131–2140.
Howard G, Walker MD, Becker C, Coull B, Feibel J, McLeroy K, Toole JF, Yatsu F: Community Hospital-based Stroke Programs: North Carolina, Oregon, and New York. 3. Factors influencing survival after stroke: Proportional hazards analysis of 4,219 patients. Stroke 1986;17:294–299.
Viitanen M, Eriksson S, Asplund K, Wester PO, Winblad B: Determinants of long-term mortality after stroke. Acta Med Scand 1987;221:349–356.
Anderson CS, Jamrozik KD, Broadhurst RJ, Stewart-Wynne EG: Predicting survival for 1 year among different subtypes of stroke. Results from the Perth Community Stroke Study. Stroke 1994;25:1935–1944.
Appelros P, Nydevik I, Seiger Å, Terént A: Predictors of severe stroke: Influence of pre-existing dementia and cardiac disorders. Stroke 2002;33:2357–2362.
Appelros P, Nydevik I, Viitanen M: Poor outcome after first-ever stroke: Predictors for death, dependency and recurrent stroke within the first year. Stroke 2003;34:122–126.
Sheikh K, Brennan PJ, Meade TW, Smith DS, Goldenberg E: Predictors of mortality and disability in stroke. J Epidemiol Community Health 1983;37:70–74.
Vemmos KN, Bots ML, Tsibouris PK, Zis VP, Takis CE, Grobbee DE, Stamatelopoulos S: Prognosis of stroke in the south of Greece: 1 year mortality, functional outcome and its determinants: The Arcadia Stroke Registry. J Neurol Neurosurg Psychiatry 2000;69:595–600.
Anderson CS, Jamrozik KD, Stewart-Wynne EG: Patterns of acute hospital care, rehabilitation, and discharge disposition after acute stroke: The Perth Community Stroke Study 1989–1990. Cerebrovasc Dis 1994;4:344–353.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.